Data Foundry

Drug recalls 2023

VANCOmycin HCI PF — Class III drug recall D-0071-2024

Terminated recall by Denver Solutions, LLC DBA Leiters Health, reported 2023-11-01, distributed nationwide. Labeling: Not Elsewhere Classified

Recall numberD-0071-2024
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmDenver Solutions, LLC DBA Leiters Health, Englewood, CO, United States
Recall initiated2023-10-04
Classified2023-10-26
Reported by FDA2023-11-01
Terminated2024-08-15
DistributedNationwide (US)
Quantity33,480 iv
Reason classeslabeling
NDC71449-0028-68
Lot numbers2330781, 2330791, 2330795, 2330800, 2330807, 2330812, 2330816, 2330822, 2330897, 2330899, 2330901, 2330918, 2330943, 2331050, 2331064, 2331102
Expiration dates2023-10-19, 2023-10-29, 2023-11-02, 2023-11-09, 2023-11-11, 2023-11-16, 2023-11-19, 2024-01-25

Product

VANCOmycin HCI PF, 1.25 g added to 0.9% Sodium Chloride 250 mL IV Bag, Rx only, Leiters Compounding Health, 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-028-68.

Reason for recall

Labeling: Not Elsewhere Classified

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0071-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.